MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 225 filers reported holding MIRATI THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.86 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $78 | +4.0% | 1,331 | -23.2% | 0.00% | +33.3% |
| Q3 2023 | $75 | +17.2% | 1,732 | -1.6% | 0.00% | 0.0% |
| Q2 2023 | $64 | -3.0% | 1,760 | -0.6% | 0.00% | 0.0% |
| Q1 2023 | $66 | -17.5% | 1,770 | -0.3% | 0.00% | -25.0% |
| Q4 2022 | $80 | -99.9% | 1,776 | -16.8% | 0.00% | -33.3% |
| Q3 2022 | $149,000 | -17.7% | 2,135 | -20.7% | 0.01% | +20.0% |
| Q2 2022 | $181,000 | -18.1% | 2,694 | +0.2% | 0.01% | 0.0% |
| Q1 2022 | $221,000 | -51.2% | 2,689 | -12.9% | 0.01% | -44.4% |
| Q4 2021 | $453,000 | -16.4% | 3,087 | +0.7% | 0.01% | -25.0% |
| Q3 2021 | $542,000 | +4.6% | 3,065 | -4.4% | 0.01% | +20.0% |
| Q2 2021 | $518,000 | +61.4% | 3,205 | +119.1% | 0.01% | +42.9% |
| Q4 2020 | $321,000 | +32.1% | 1,463 | 0.0% | 0.01% | +16.7% |
| Q3 2020 | $243,000 | +45.5% | 1,463 | 0.0% | 0.01% | +50.0% |
| Q2 2020 | $167,000 | – | 1,463 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $257,839,000 | 68.01% |
| Boxer Capital, LLC | 2,000,000 | $164,440,000 | 8.45% |
| Avoro Capital Advisors LLC | 5,325,000 | $437,822,000 | 7.99% |
| M28 Capital Management LP | 82,900 | $6,816,000 | 6.27% |
| Artal Group S.A. | 1,350,000 | $110,997,000 | 4.65% |
| Nextech Invest Ltd. | 173,300 | $14,249,000 | 4.07% |
| Perceptive Advisors | 2,380,710 | $195,742,000 | 3.92% |
| Logos Global Management LP | 350,000 | $28,777,000 | 3.73% |
| Camber Capital Management LP | 1,200,000 | $98,664,000 | 3.57% |
| RTW INVESTMENTS, LP | 1,561,497 | $128,386,000 | 2.66% |